Cited 2 time in
Guidelines on implementing antimicrobial stewardship programs in Korea
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yoon, Young Kyung | - |
| dc.contributor.author | Kwon, Ki Tae | - |
| dc.contributor.author | Jeong, Su Jin | - |
| dc.contributor.author | Moon, Chisook | - |
| dc.contributor.author | Kim, Bongyoung | - |
| dc.contributor.author | Kiem, Sungmin | - |
| dc.contributor.author | Kim, Hyung-sook | - |
| dc.contributor.author | Heo, Eunjeong | - |
| dc.contributor.author | Kim, Shin-Woo | - |
| dc.contributor.author | Korean Society for Antimicrobial Therapy | - |
| dc.contributor.author | Korean Society of Infectious Diseases | - |
| dc.contributor.author | Korean Society of Health-System Pharmacist | - |
| dc.date.accessioned | 2022-07-06T13:01:53Z | - |
| dc.date.available | 2022-07-06T13:01:53Z | - |
| dc.date.issued | 2021-09 | - |
| dc.identifier.issn | 2093-2340 | - |
| dc.identifier.issn | 2092-6448 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140974 | - |
| dc.description.abstract | These guidelines were developed as a part of the 2021 Academic R&D Service Project of the Korea Disease Control and Prevention Agency in response to requests from healthcare professionals in clinical practice for guidance on developing antimicrobial stewardship programs (ASPs). These guidelines were developed by means of a systematic literature review and a summary of recent literature, in which evidence-based intervention methods were used to address key questions about the appropriate use of antimicrobial agents and ASP expansion. These guidelines also provide evidence of the effectiveness of ASPs and describe intervention methods applicable in Korea. | - |
| dc.format.extent | 43 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy | - |
| dc.title | Guidelines on implementing antimicrobial stewardship programs in Korea | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3947/IC.2021.0098 | - |
| dc.identifier.scopusid | 2-s2.0-85117301117 | - |
| dc.identifier.wosid | 000703738600025 | - |
| dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.53, no.3, pp 617 - 659 | - |
| dc.citation.title | Infection and Chemotherapy | - |
| dc.citation.volume | 53 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 617 | - |
| dc.citation.endPage | 659 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002763766 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Infectious Diseases | - |
| dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
| dc.subject.keywordPlus | CLOSTRIDIUM-DIFFICILE INFECTION | - |
| dc.subject.keywordPlus | COMMUNITY-ACQUIRED PNEUMONIA | - |
| dc.subject.keywordPlus | DECISION-SUPPORT-SYSTEM | - |
| dc.subject.keywordPlus | GRAM-NEGATIVE BACTERIA | - |
| dc.subject.keywordPlus | VENTILATOR-ASSOCIATED PNEUMONIA | - |
| dc.subject.keywordPlus | URINARY-TRACT-INFECTIONS | - |
| dc.subject.keywordPlus | HEALTH-CARE EPIDEMIOLOGY | - |
| dc.subject.keywordPlus | BLOOD-STREAM INFECTIONS | - |
| dc.subject.keywordPlus | HIGH-RISK ANTIBIOTICS | - |
| dc.subject.keywordPlus | PROSPECTIVE-AUDIT | - |
| dc.subject.keywordAuthor | Antimicrobial stewardship program | - |
| dc.subject.keywordAuthor | Guidelines | - |
| dc.subject.keywordAuthor | Korea | - |
| dc.subject.keywordAuthor | Antimicrobial resistance | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
